Fineotex Chemical Ltd
Fineotex Chemical Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 4 strong
Not discussed on this call: fundraise.
The short version
Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. Fineotex Chemicals anticipates strong revenue and profit growth driven by expanded Texas facility capacity and healthy demand in the U.S.
From Fineotex Chemical Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. INR 1,000 crores in FY'26.
- The company expects organic growth aided by sustainability trends and replication of product lines in global markets.
- Texas plant has expanded capacity to 1,48,000 MTPA with current utilization around 63-65%; plans to increase utilization to peak in coming quarters.
- Potential exists to double production by running two shifts with minimal additional capex (~USD 1-2 million).
- Growth driven by increasing wallet share in oil & gas markets across USA, Canada, Venezuela, Gulf countries, Saudi Arabia, and new markets like Suriname and Guyana.
- Textile business expected to recover from seasonal dips; moderate growth aligned with 5-7% industry CAGR.
- Crude oil price fluctuations are not expected to significantly impact growth trajectory.
- Focus on green/sustainable chemical solutions bolsters long-term revenue expansion.
Profitability & Margins
See what Fineotex Chemical Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Fineotex Chemicals invested significantly in expanding its Texas facility, adding 69,000 MTPA capacity, increasing total capacity to 268,000 MTPA, enhancing ability to serve larger customer contracts and drive growth.
- The CrudeChem Group acquisition provided growth capital enabling capacity expansion and ramp-up; additional minor capex of USD 1-2 million anticipated for doubling shifts or enhancing capacity.
- Company remains cash disciplined with high cash on book and continues to monitor for selective inorganic growth opportunities with focus on synergy and value.
- Further capital infusion helped secure better pricing from suppliers, improving EBITDA margins.
- No major capex concerns currently; incremental capital investments are relatively small compared to growth potential.
- Expansion expected to enable capacity utilization to reach peak in coming quarters.
- Ongoing investments in R&D, production, and supplier alliances to support operational efficiency and product quality.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fineotex Chemical Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- There is no traditional "order book" system like government tenders; orders vary with oil and gas cycles.
- Business depends on delivering value as per client needs, with a focus on sustainable solutions.
- Once a well starts production, work is generally perennial and cannot be stopped abruptly.
- The company experiences fluctuations due to weather and operational cycles but maintains steady demand.
- Strong ongoing order flow is indicated, with existing expanded capacities being utilized (~63% utilized recently).
- CrudeChem has a solid pipeline, and capacity expansion is expected to support higher order volumes soon.
- The management emphasizes focusing on customer relationships and sustainability rather than fixed order backlog.
Fineotex Chemical Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹314 Cr, net profit ₹44 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fineotex Chemical Ltd's management said in earlier quarters
- Q4 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q2 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q3 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Frequently Asked Questions
What were Fineotex Chemical Ltd Q1 FY27 results?
Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. Fineotex Chemicals anticipates strong revenue and profit growth driven by expanded Texas facility capacity and healthy demand in the U.S.
What is Fineotex Chemical Ltd share price analysis?
Fineotex Chemical Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 45.1 with a market cap of ₹5,523 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fineotex Chemical Ltd planning capital expenditure?
Fineotex Chemicals invested significantly in expanding its Texas facility, adding 69,000 MTPA capacity, increasing total capacity to 268,000 MTPA, enhancing ability to serve larger customer contracts and drive growth.
Keep Fineotex Chemical Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.